- BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
- BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
- BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
- BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
- BioAtla to Participate in the Jefferies London Healthcare Conference
- BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
- BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
- BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- BioAtla to Participate in Upcoming Investor Conferences in August
More ▼
Key statistics
On Wednesday, Bioatla Inc (BCAB:NMQ) closed at 3.37, -17.16% below its 52-week high of 4.07, set on May 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.26 |
---|---|
High | 3.53 |
Low | 2.26 |
Bid | 3.22 |
Offer | 3.33 |
Previous close | 2.26 |
Average volume | 900.93k |
---|---|
Shares outstanding | 48.11m |
Free float | 43.37m |
P/E (TTM) | -- |
Market cap | 108.48m USD |
EPS (TTM) | -2.58 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼